サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1732884

牛の健康市場- 世界の産業規模、シェア、動向、機会、予測、治療薬別、診断薬別、地域別、競合別、2020-2030年

Cattle Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutics and By Diagnostics, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 182 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

牛の健康市場- 世界の産業規模、シェア、動向、機会、予測、治療薬別、診断薬別、地域別、競合別、2020-2030年
出版日: 2025年05月23日
発行: TechSci Research
ページ情報: 英文 182 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

牛の健康の世界市場は、2024年には99億8,000万米ドルとなり、2030年には160億7,000万米ドルに達すると予測され、予測期間中のCAGRは8.22%で成長すると予測されています。

牛の健康は、食肉、牛乳、その他の農業用途のために飼育される牛の全体的な幸福と生産性を包含します。最適な牛の健康を維持することは、動物福祉、経済効率、動物由来製品の安全性を確保するために極めて重要です。人口増加や所得水準の向上により、食肉や乳製品に対する世界の需要が高まり、牛の健康ソリューションへの投資に拍車がかかっています。予防接種、バイオセキュリティプロトコル、牛群管理戦略などの予防ヘルスケアは、疾病リスクの軽減と生産性の向上に不可欠です。獣医学的診断と治療技術の進歩は、牛の健康の管理をさらに強化しています。さらに、規制当局の支援と、食品の安全性と持続可能な畜産慣行に関する消費者の意識の高まりが、市場の上昇軌道に寄与しています。

市場概要
予測期間 2026-2030
市場規模：2024年 99億8,000万米ドル
市場規模：2030年 160億7,000万米ドル
CAGR：2025年～2030年 8.22%
急成長セグメント 医療用飼料添加物
最大市場 北米

市場促進要因

技術の進歩

主な市場課題

疾病の発生

主要市場動向

トレーサビリティと食品安全

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界の牛の健康市場に与える影響

第5章 顧客の声

第6章 世界の牛の健康市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 治療薬別（ワクチン、駆虫薬、抗感染薬、医療用飼料添加物、その他の治療薬）
    • 診断別（免疫診断検査、分子診断、診断画像、臨床化学、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第7章 アジア太平洋地域の牛の健康市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第8章 欧州の牛の健康市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • 英国

第9章 北米の牛の健康市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米の牛の健康市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの牛の健康市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第14章 世界の牛の健康市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 PESTEL分析

第17章 競合情勢

  • Qiagen LLC
  • Boehringer Ingelheim
  • Thermo Fisher Scientific
  • Elanco Animal Health
  • Idexx Laboratories
  • ID Vet
  • Kyoritsuseiyaku Corporation
  • Merck & Co Inc.
  • Norbrook laboratories

第17章 10ゾエティス株式会社

第18章 戦略的提言

第19章 調査会社について・免責事項

目次
Product Code: 16128

The Global Cattle Health Market was valued at USD 9.98 billion in 2024 and is projected to reach USD 16.07 billion by 2030, growing at a CAGR of 8.22% during the forecast period. Cattle health encompasses the overall well-being and productivity of cattle, which are raised for meat, milk, and other agricultural uses. Maintaining optimal cattle health is crucial for ensuring animal welfare, economic efficiency, and the safety of animal-derived products. The rising global demand for meat and dairy, driven by population growth and increasing income levels, is spurring investment in cattle health solutions. Preventive healthcare practices such as vaccinations, biosecurity protocols, and herd management strategies are essential for mitigating disease risks and enhancing productivity. Advancements in veterinary diagnostics and treatment technologies are further strengthening cattle health management. In addition, regulatory support and growing consumer awareness regarding food safety and sustainable livestock practices are contributing to the market's upward trajectory.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 9.98 Billion
Market Size 2030USD 16.07 Billion
CAGR 2025-20308.22%
Fastest Growing SegmentMedical Feed Additives
Largest MarketNorth America

Key Market Drivers

Technological Advancements

The cattle health sector is witnessing rapid technological evolution, with smart farming tools playing a key role in monitoring and managing animal well-being. Wearable sensors track vital parameters like temperature, heart rate, and movement, enabling early illness detection. The integration of data analytics allows farmers to interpret large volumes of herd health data, leading to informed decision-making. Remote monitoring using drones and satellite imaging supports pasture management and herd surveillance. Precision livestock farming customizes feeding, medication, and environmental conditions to individual animal needs, enhancing efficiency and outcomes. Blockchain ensures traceability across the cattle lifecycle, boosting transparency and safety. Genetic testing is increasingly used for selecting disease-resistant cattle and improving herd quality, driving innovation in breeding programs.

Key Market Challenges

Disease Outbreaks

Rising global cattle populations have heightened the risk and impact of disease outbreaks, presenting a significant challenge to cattle health management. In 2023, over 65 countries reported widespread cases of diseases such as Foot-and-Mouth Disease, Lumpy Skin Disease, and Bovine Tuberculosis, according to the World Organisation for Animal Health (WOAH). These outbreaks result in major economic setbacks due to reduced productivity, higher veterinary costs, and animal losses from culling mandates. The Food and Agriculture Organization (FAO) reported substantial declines in milk yield and cattle weight in affected regions, with severe implications for profitability. Managing and mitigating the effects of such outbreaks remains a key concern for stakeholders in the cattle industry.

Key Market Trends

Traceability and Food Safety

There is growing consumer demand for transparency and assurance in meat and dairy production, fueling the adoption of traceability systems in cattle farming. These systems offer end-to-end visibility, allowing consumers to access information about cattle origin, farming practices, and processing history. Regulatory authorities have mandated stringent traceability and food safety compliance, compelling producers to adopt robust tracking mechanisms. In cases of contamination or disease, such systems enable swift identification and containment, minimizing wider impacts. Traceability also supports disease surveillance and control, enhancing supply chain reliability. Innovations such as blockchain are being leveraged to secure data integrity, while genetic traceability is gaining momentum for breed verification and quality assurance.

Key Market Players

  • Qiagen LLC
  • Boehringer Ingelheim
  • Thermo Fisher Scientific
  • Elanco Animal Health
  • Idexx Laboratories
  • ID Vet
  • Kyoritsuseiyaku Corporation
  • Merck & Co Inc.
  • Norbrook laboratories
  • Zeotis Inc

Report Scope:

In this report, the Global Cattle Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cattle Health Market, By Therapeutics:

  • Vaccine
  • Parasiticide
  • Anti-infective
  • Medical Feed Additive
  • Other Therapeutics

Cattle Health Market, By Diagnostics:

  • Immunodiagnostic Test
  • Molecular Diagnostics
  • Diagnostic Imaging
  • Clinical Chemistry
  • Other Diagnostics

Cattle Health Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cattle Health Market.

Available Customizations:

Global Cattle Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Cattle Health Market

5. Voice of Customer

6. Global Cattle Health Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapeutics (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, and Other Therapeutics)
    • 6.2.2. By Diagnostics (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other s)
    • 6.2.3. By Region
    • 6.2.4. By Company (2024)
  • 6.3. Market Map

7. Asia Pacific Cattle Health Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapeutics
    • 7.2.2. By Diagnostics
    • 7.2.3. By Country
  • 7.3. Asia Pacific: Country Analysis
    • 7.3.1. China Cattle Health Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapeutics
        • 7.3.1.2.2. By Diagnostics
    • 7.3.2. India Cattle Health Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapeutics
        • 7.3.2.2.2. By Diagnostics
    • 7.3.3. Australia Cattle Health Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapeutics
        • 7.3.3.2.2. By Diagnostics
    • 7.3.4. Japan Cattle Health Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Therapeutics
        • 7.3.4.2.2. By Diagnostics
    • 7.3.5. South Korea Cattle health Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Therapeutics
        • 7.3.5.2.2. By Diagnostics

8. Europe Cattle Health Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutics
    • 8.2.2. By Diagnostics
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cattle health Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapeutics
        • 8.3.1.2.2. By Diagnostics
    • 8.3.2. Germany Cattle Health Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapeutics
        • 8.3.2.2.2. By Diagnostics
    • 8.3.3. Spain Cattle Health Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapeutics
        • 8.3.3.2.2. By Diagnostics
    • 8.3.4. Italy Cattle Health Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapeutics
        • 8.3.4.2.2. By Diagnostics
    • 8.3.5. United Kingdom Cattle Health Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapeutics
        • 8.3.5.2.2. By Diagnostics

9. North America Cattle Health Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutics
    • 9.2.2. By Diagnostics
    • 9.2.3. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Cattle Health Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutics
        • 9.3.1.2.2. By Diagnostics
    • 9.3.2. Mexico Cattle Health Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutics
        • 9.3.2.2.2. By Diagnostics
    • 9.3.3. Canada Cattle Health Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutics
        • 9.3.3.2.2. By Diagnostics

10. South America Cattle health Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutics
    • 10.2.2. By Diagnostics
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cattle Health Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutics
        • 10.3.1.2.2. By Diagnostics
    • 10.3.2. Argentina Cattle Health Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutics
        • 10.3.2.2.2. By Diagnostics
    • 10.3.3. Colombia Cattle Health Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutics
        • 10.3.3.2.2. By Diagnostics

11. Middle East and Africa Cattle Health Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutics
    • 11.2.2. By Diagnostics
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cattle health Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutics
        • 11.3.1.2.2. By Diagnostics
    • 11.3.2. Saudi Arabia Cattle Health Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutics
        • 11.3.2.2.2. By Diagnostics
    • 11.3.3. UAE Cattle Health Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutics
        • 11.3.3.2.2. By Diagnostics

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Product Launches
  • 13.3. Mergers & Acquisitions

14. Global Cattle Health Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

  • 17.1. Qiagen LLC
    • 17.1.1. Business Overview
    • 17.1.2. Company Snapshot
    • 17.1.3. Products & Services
    • 17.1.4. Financials (As Reported)
    • 17.1.5. Recent Developments
    • 17.1.6. Key Personnel Details
    • 17.1.7. SWOT Analysis
  • 17.2. Boehringer Ingelheim
  • 17.3. Thermo Fisher Scientific
  • 17.4. Elanco Animal Health
  • 17.5. Idexx Laboratories
  • 17.6. ID Vet
  • 17.7. Kyoritsuseiyaku Corporation
  • 17.8. Merck & Co Inc.
  • 17.9. Norbrook laboratories

17.10 Zoetis Inc. Inc.

18. Strategic Recommendations

19. About Us & Disclaimer

OSZAR »